Literature DB >> 14740555

[Expression of TGF-beta receptor II in periretinal membranes of proliferative vitreoretinopathy].

Changmei Guo1, Yannian Hui, Jixian Ma, Quanhong Han, Feng Yan, Xiangyang Qin, Jianzhou Wang.   

Abstract

PURPOSE: To investigate the expression of transforming growth factor-beta receptor II (TGF-beta R II) in periretinal membranes of proliferative vitreoretinopathy (PVR).
METHODS: Immunohistochemistry and in situ hybridization were used to detect the expression of TGF-beta R II protein and mRNA in sixteen proliferative membranes of thirteen PVR patients.
RESULTS: Immunohistochemically staining showed that membranes labeled negative "-", weak positive "+", positive "2+" and strong positive staining "3+" were respectively noted one, one, three and four membranes in nine C2-C3 membranes. Total positive cell rate is 88.9%. Among seven D1-D3 membranes, one membrane was labeled "-", three were "+" and another three membranes were labeled "2+". Total positive cell rate is 85.7%. Positive staining cells were of a type of epithelial-like cells which frequently found pigment in or around them. Relation between TGF-beta R II expression and membrane grades appeared no correlation (P > 0.05). Results of in situ hybridization were almost consistent with that of immunohistochemistry.
CONCLUSIONS: Both TGF-beta R II protein and mRNA are highly expressed and up-regulated in PVR membranes by cytokine stimulation, moreover TGF-beta may play important role in the pathogenesis of PVR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740555

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  1 in total

1.  P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.

Authors:  Lauren Schiff; Nathan C Boles; Marie Fernandes; Bar Nachmani; Ronald Gentile; Timothy A Blenkinsop
Journal:  Commun Biol       Date:  2019-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.